Open Access<p>Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review</p>
Author(s) -
Getnet Teshome,
Sintayehu Ambachew,
Alebachew Fasil,
Molla Abebe
Publication year - 2020
Publication title -
hepatic medicine
Language(s) - English
Resource type - Journals
ISSN - 1179-1535
DOI - 10.2147/hmer.s265631
Subject(s) - nonalcoholic fatty liver disease , medicine , insulin resistance , gastroenterology , adiponectin , alanine transaminase , fatty liver , cochrane library , metabolic syndrome , liver disease , randomized controlled trial , endocrinology , insulin , disease , obesity
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. It is believed to be the hepatic manifestation of the metabolic syndrome. Many treatment approaches have been suggested so far, and several types of studies have been done to find treatment for NAFLD, the most promising of which are those with lifestyle interventions.